Liver biopsy assessment by pathologists remains the gold standard for diagnosing metabolic dysfunction-associated steatotic liver disease (MASLD). Current automated image analysis tools for patient risk stratification are often proprietary or not applicable to whole slide images (WSIs). Here, we introduce "Liver-Quant," an open-source Python package for quantifying steatosis and fibrosis in liver WSIs. Liver-Quant leverages colour and morphological features to measure Steatosis Proportionate Area (SPA) and Collagen Proportionate Area (CPA). We evaluated the method using an internal dataset of 414 WSIs from adult patients (Leeds Teaching Hospitals NHS Trust, 2016-2022) and an external public dataset (109 WSIs). Semi-quantitative scores were extracted from pathological reports. The Spearman rank coefficient (ρ) assessed correlations between computed SPA/CPA and pathologist scores. Steatosis quantification showed a substantial correlation (ρ = 0.92), while fibrosis quantification yielded a moderate correlation (ρ = 0.51). We further investigated the impact of three staining dyes (Van Gieson (VG), Picro Sirius Red (PSR), and Masson's Trichrome (MTC)) on fibrosis quantification (n = 18). Stain normalisation yielded excellent agreement in CPA measurements across all three stains. Without normalisation, PSR achieved the strongest correlation with human scores (ρ = 0.9) followed by VG (ρ = 0.8) and MTC (ρ = 0.59). Finally, we explored the impact of apparent magnification on SPA and CPA. High-resolution images (0.25 or 0.50 μm per pixel (MPP)) were necessary for accurate SPA measurement, while lower resolution (10 MPP) sufficed for CPA measurements. Liver-Quant offers an open-source solution for rapid and precise MASLD quantification in WSIs applicable to multiple histological stains.
Introduction: The histological assessment of liver biopsies by pathologists serves as the gold standard for diagnosing metabolic dysfunction-associated steatotic liver disease (MASLD) and staging disease progression. Various machine learning and image analysis tools have been reported to automate the quantification of fatty liver and enhance patient risk stratification. However, the current software is either not open-source or not directly applicable to the whole slide images (WSIs). Methods: In this paper, we introduce “ Liver-Quant ,” an open-source Python package designed for quantifying fat and fibrosis in liver WSIs. Employing colour and morphological features, Liver-Quant measures the Steatosis Proportionate Area (SPA) and Collagen Proportionate Area (CPA). The method’s accuracy and robustness were evaluated using an internal dataset of 424 WSIs from adult patients collected retrospectively from the archives at Leeds Teaching Hospitals NHS Trust between 2016 and 2022 and an external public dataset of 109 WSIs. For each slide, semi-quantitative scores were automatically extracted from free-text pathological reports. Furthermore, we investigated the impact of three different staining dyes including Van Gieson (VG), Picro Sirius Red (PSR), and Masson’s Trichrome (MTC) on fibrosis quantification. Results: The Spearman rank coefficient (ρ) was calculated to assess the correlation between the computed SPA/CPA values and the semi-quantitative pathologist scores. For steatosis quantification, we observed a substantial correlation (ρ=0.92), while fibrosis quantification exhibited a moderate correlation with human scores (ρ=0.51). To assess stain variation on CPA measurement, we collected N=18 cases and applied the three stains. Employing stain normalisation, an excellent agreement was observed in CPA measurements among the three stains using Bland-Altman plots. However, without stain normalisation, PSR emerged as the most effective dye due to its enhanced contrast in the Hue channel, displaying a strong correlation with human scores (ρ=0.9), followed by VG (ρ=0.8) and MTC (ρ=0.59). Additionally, we explored the impact of the apparent magnification on SPA and CPA. High resolution images collected at 0.25 microns per pixel (MPP) [apparent magnification = 40x] or 0.50 MPP [apparent magnification = 20x] were found to be essential for accurate SPA measurement, whereas for CPA measurement, low resolution images collected at 10 MPP [apparent magnification = 1x] were sufficient. Conclusion: The Liver-Quant package offers an open-source solution for rapid and precise liver quantification in WSIs applicable to multiple histological stains.
The introduction of CFTR modulators has been transformative for many people with cystic fibrosis (CF). The drugs are generally well tolerated although adverse reactions such as delayed-type T-cell mediated hypersensitivity and drug-induced liver injury (DILI) have been reported. Here, we characterise a novel underlying immunological mechanism driving DILI post Elexacaftor/Tezacaftor/Ivacaftor (ETI) administration. Liver-infiltrating T-cells were isolated, post liver biopsy, using a collagenase digestion protocol. Phenotypic analysis of isolated T-cell populations was conducted using flow cytometry and mass cytometry (CyTOF). Lymphocyte transformation tests (LTT) were conducted to detect CFTR modulator-specific T-cell proliferation ([3H]-thymidine). Cytokine analysis was performed using intracellular cytokine staining and enzyme-linked immunospot assays. Liver function tests and histological examination of liver tissue revealed elevated alanine transaminase levels and evidence of perivenular zone three confluent necrosis and hepatocyte loss with mixed inflammatory infiltrate of lymphocytes. T-cells isolated from a percutaneous liver punch biopsy were associated with a dominant CD8+ cellular phenotype. Phenotypic analysis also revealed a CD45RO+ memory phenotype alongside expression of trafficking and migratory markers, such as CXCR3 and LFA-1. In vitro antigen specificity testing demonstrated significant proliferative T-cell responses after exposure to Ivacaftor, Ivacaftor M1 and Ivacaftor M6 metabolites within populations of CD3+ liver-infiltrating T-cells, but not peripheral blood mononuclear cells. CFTR modulator-specific T-cells appear to be localised to sites of liver injury and not present at high frequencies within peripheral blood. Our findings align with pathomechanisms of immune-mediated DILI, during which drug-activated T-cells migrate towards sites of inflammation, infiltrate tissues and induce hepatotoxicity.
Digital pathology is an important resource in modern pathology education, with many examples of large databases of educational cases now available online. However, there remains a lack of standardization in retrieval and categorization of cases for training within and between institutions. Over 1600 teaching terms applicable to histopathology were developed and mapped to corresponding SNOMED CT terms to create a large directory of teaching cases. This was then integrated as a pre-defined list into a clinical PACS system for a national digital pathology project covering multiple hospitals and pathology training programs. This resource allows easy allocation of teaching term labels to cases with educational value. A substantial catalog of educational cases has been generated already, with ongoing efforts to expand this with cases from routine clinical practice. The catalog is fully searchable by term for use in training and examinations. A large directory of digital pathology teaching cases was developed with associated corresponding SNOMED CT terms. The directory of terms will be shared with other healthcare providers to expand its use and utility.
Objective Checkpoint inhibitor (CPI)-induced cholangiopathy is a rare phenotype of checkpoint inhibitor-induced liver injury (ChILI). The diagnosis is usually delayed, and its management is challenging due to lack of evidence. This review aims to summarise the current evidence on CPI-induced cholangiopathy to help physicians in the diagnosis and management in clinical practice and highlight knowledge gaps. Methods A comprehensive literature review was conducted on the incidence, clinical presentation, investigations, management and outcome of CPI-induced cholangiopathy. Results CPI-induced cholangiopathy occurs predominantly after exposure to programmed cell death protein 1 inhibitors. Most patients are asymptomatic with a mixed/cholestatic pattern of liver injury. Three-quarters of patients have bile duct abnormalities on Magnetic Resonance Cholangiopancreatography (MRCP), commonly affecting intrahepatic and extrahepatic ducts. Sclerosing cholangiopathy is seen in almost 25% with radiological abnormalities. Liver biopsy can aid in the diagnosis and exclude other pathology in those with normal imaging. CPI-induced cholangiopathy has a poor biochemical response to immunosuppression regimens recommended by oncology guidelines, while 25% improve spontaneously without any treatment. Ursodeoxycholic acid (UDCA) is commonly used, although its efficacy is unclear. Elevated liver enzymes can persist for months, with up to 20% of patients demonstrating abnormal liver enzymes for more than 6 months. Conclusion Early clinical suspicion of CPI-induced cholangiopathy is needed in all suspected ChILI with mixed/cholestatic patterns. Biliary imaging with or without biopsy is needed to establish the diagnosis. There is no evidence-based treatment, and the recovery period is usually prolonged. Response to immunosuppression is limited and initiating UDCA can be considered in all patients.
13 June 2025 in The Journal of Pathology: Clinical Research
External Quality Assessment (EQA) schemes are an important quality assurance tool and aim to ensure consistency among histopathologists. In this study, we use Shannon entropy as a novel metric to evaluate linguistic variability in the UK Liver Pathology EQA scheme. Analysing free‐text responses by participants over a decade, we aimed to quantify language trends in morphological assessments and clinicopathological diagnoses. Accounting for an increasing word count and when pathologists joined the scheme, our findings reveal a significant increase in entropy of morphological assessments over time, indicating growing linguistic diversity that may reflect the increasing complexity of liver pathology. Entropy of clinicopathological diagnoses over the same period did not provide clear evidence for convergent diagnostic language. High entropy corresponded to cases that elicited more diverse responses and could be considered more challenging, highlighting the utility of this method to identify potential areas for targeted education. We demonstrate entropy as a novel tool to analyse pathologist language and enhance quality assurance in the evolving pathology landscape.
About Me
Dr Cratchley is a subspecialised Liver pathologist in the UK working in a large tertiary transplant centre.
Dr Cratchley is a subspecialised Liver pathologist in the UK working in a large tertiary transplant centre.